Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Open Angle Glaucoma: Treatment

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...

Angle Closure Glaucoma: Treatment

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...

Glaucoma: Overview

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...

Direct-Acting Cholinergic Agonists: Therapeutic Uses

Direct-Acting Cholinergic Agonists: Therapeutic Uses

Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren syndrome.

Ophthalmic Drug Delivery Systems

Ophthalmic Drug Delivery Systems

Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...

Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers

Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers

β-receptor blockers significantly impact the cardiovascular system by counteracting catecholamine-induced sympathetic responses. These medications decrease heart rate, contractility, and cardiac output, potentially leading to cardiac depression, life-threatening bradycardia, and death. Therapeutically, β-blockers function as mild antihypertensives and are utilized in treating angina pectoris and cardiac arrhythmias. However, nonselective β-blockers inhibit β2-receptors in bronchial smooth...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Sodium Metabisulfite Inhibits <i>Acanthamoeba</i> Trophozoite Growth through Thiamine Depletion.

Pathogens (Basel, Switzerland)·2024

Same author

NOVEL APPLICATION OF DEEP ANTERIOR LAMELLAR KERATOPLASTY FOR RETINAL DETACHMENT REPAIR IN TOTALLY OPAQUE CORNEA SECONDARY TO ANIRIDIA.

Retinal cases & brief reports·2023

Same author

Potential cost of assumptions within a visual assessment.

BMJ case reports·2023

Same author

Case for conservative management of adenoviral pseudomembranous conjunctivitis.

BMJ case reports·2023

Same author

Novel Map Biopsy Technique to Define the Extent of Infection Before Penetrating Keratoplasty for Acanthamoeba Keratitis.

Cornea·2023

Same author

Estimations of Critical Clear Corneal Incisions Required for Lens Insertion in Cataract Surgery: A Mathematical Aspect.

Frontiers in physiology·2022

Same journal

Trigger tool methodologies in hospital settings: reappraising their role in pharmacovigilance and digital safety surveillance.

Expert opinion on drug safety·2026

Same journal

Could anticholinergics accelerate ALS progression? A critical perspective on drug safety and disease vulnerability.

Expert opinion on drug safety·2026

Same journal

Safety profile of teprotumumab-trbw, the first and only FDA-approved treatment for thyroid-associated ophthalmopathy.

Expert opinion on drug safety·2026

Same journal

A systematic review and meta-analysis of safety and efficacy parameters of sotatercept in the therapy of pulmonary arterial hypertension.

Expert opinion on drug safety·2026

Same journal

Tirzepatide data: safety first is safety always!

Expert opinion on drug safety·2026

Same journal

An update on the safety of biologics for the treatment of psoriasis.

Expert opinion on drug safety·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Jun 14, 2026

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation

Published on: March 12, 2016

Brimonidine for glaucoma.

Mamun Q Rahman¹, Kanna Ramaesh, Donald M I Montgomery

¹Gartnavel General Hospital, Tennent Institute of Ophthalmology, Glasgow, UK. mmnrahman@hotmail.com

Expert Opinion on Drug Safety

|April 7, 2010

Summary

This summary is machine-generated.

Brimonidine effectively lowers intraocular pressure for glaucoma patients but has contraindications in children due to systemic effects and can cause ocular side effects in adults. It remains a valuable treatment option.

Related Experiment Videos

Last Updated: Jun 14, 2026

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation

Published on: March 12, 2016

Area of Science:

Ophthalmology
Pharmacology

Background:

Brimonidine is a modern alpha(2)-adrenoceptor agonist widely used globally for glaucoma management.
This review provides a comprehensive overview of brimonidine's application in treating glaucoma.

Purpose of the Study:

To review the efficacy, limitations, and clinical application of brimonidine in glaucoma treatment.
To evaluate the safety profile and provide expert opinion on brimonidine's use.

Main Methods:

Historical overview of selective adrenergic glaucoma drugs.
Description of brimonidine's mechanisms of action.
Discussion of key clinical trials and relevant literature.

Main Results:

Brimonidine demonstrates efficacy in reducing intraocular pressure.
Identified limitations include potential systemic effects in children and ocular side effects in adults.

Conclusions:

Brimonidine is an effective agent for lowering intraocular pressure.
Contraindicated in children due to systemic risks; adult use may be limited by ocular side effects like allergy.
It is an important therapeutic option within the available glaucoma medications.